Thought Leadership
FDA's Longtime Approach to New Chemical Entity Designations Now Codified
June 14, 2021
Stacie Ropka, PhD and Ramya Auroprem
Outsourced Pharma and Pharmaceutical Online

Axinn partner Stacie Ropka and associate Ramya Auroprem co-authored the Outsourced Pharma and Pharmaceutical Online article, "FDA's Longtime Approach to New Chemical Entity Designations Now Codified."

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.